{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:58:01Z","timestamp":1770818281382,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["260648\/SVV\/2024"],"award-info":[{"award-number":["260648\/SVV\/2024"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009532","name":"Ministry of the Interior of the Czech Republic","doi-asserted-by":"publisher","award":["VK01010212"],"award-info":[{"award-number":["VK01010212"]}],"id":[{"id":"10.13039\/100009532","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pnpbp.2025.111285","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T11:05:39Z","timestamp":1739012739000},"page":"111285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The acute effects of methoxphenidine on behaviour and pharmacokinetics profile in animal model"],"prefix":"10.1016","volume":"137","author":[{"given":"Krist\u00fdna","family":"\u0160tefkov\u00e1-Mazochov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hynek","family":"Danda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Mazoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Olejn\u00edkov\u00e1-Ladislavov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kl\u00e1ra","family":"\u0160\u00edchov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lie","family":"Pa\u0161kanov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdal\u00e9na","family":"V\u00e1gnerov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronislav","family":"Jur\u00e1sek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Ry\u0161\u00e1nek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"\u0160\u00edma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"\u0160afanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quang Hiep","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kucha\u0159","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"P\u00e1len\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2025.111285_bb0005","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","article-title":"Models of schizophrenia in humans and animals based on inhibition of NMDA receptors","volume":"32","author":"Buben\u00edkov\u00e1-Vale\u0161ov\u00e1","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002130050856","article-title":"Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats","volume":"142","author":"De Bruin","year":"1999","journal-title":"Psychopharmacology"},{"issue":"272","key":"10.1016\/j.pnpbp.2025.111285_bb0015","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"A multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J. Am. Stat. Assoc."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111285_bb0020","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/fcp.12395","article-title":"Ephenidine, diphenidine, and methoxphenidine complications reported to the French addictovigilance network","volume":"32","author":"Eiden","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111285_bb0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jat\/bkv006","article-title":"First reported fatalities associated with the \u2018research chemical\u2019 2-methoxydiphenidine","volume":"39","author":"Elliott","year":"2015","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111285_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/dta.2225","article-title":"Assessing the toxicological significance of new psychoactive substances in fatalities","volume":"10","author":"Elliott","year":"2018","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111285_bb0040","series-title":"Preparation of 1, 2-Diarylethylamines for Treatment of Neurotoxic Injury. Patent EP346791A1","first-page":"20","author":"Gray","year":"1989"},{"key":"10.1016\/j.pnpbp.2025.111285_bb0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00213-016-4203-3","article-title":"The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents","volume":"233","author":"Halberstadt","year":"2016","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111285_bb0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0024-3205(82)90708-1","article-title":"Pharmacological activity and toxicity of phencyclidine (PCP) and phenylcyclohexene (PC), a pyrolysis product","volume":"31","author":"Holsapple","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainresbull.2016.05.002","article-title":"Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue\u2014behavioural, pharmacokinetic and metabolic studies in the Wistar rat","volume":"126","author":"Horsley","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"19","key":"10.1016\/j.pnpbp.2025.111285_bb0060","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1111\/bph.15528","article-title":"Methoxphenidine (MXP) induced abnormalities: addictive and schizophrenia-related behaviours based on an imbalance of neurochemicals in the brain","volume":"178","author":"Hur","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2025.111285_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(00)00055-8","article-title":"Effects of scopolamine in comparison with apomorphine and phencyclidine on prepulse inhibition in rats","volume":"391","author":"Jones","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111285_bib166","article-title":"Alboukadel. \"rstatix: Pipe-friendly framework for basic statistical tests","author":"Kassambara","year":"2019","journal-title":"CRAN: Contributed Packages"},{"key":"10.1016\/j.pnpbp.2025.111285_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173333","article-title":"Rewarding and reinforcing effects of two dissociative-based new psychoactive substances, deschloroketamine and diphenidine, in mice","volume":"213","author":"Kim","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.heares.2016.06.006","article-title":"Prepulse inhibition of the acoustic startle reflex vs. auditory brainstem response for hearing assessment","volume":"339","author":"Longenecker","year":"2016","journal-title":"Hear. Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111285_bb0080","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0893-133X(00)00147-0","article-title":"\u201cEarly\u201d and \u201clate\u201d effects of sustained haloperidol on apomorphine-and phencyclidine-induced sensorimotor gating deficits","volume":"23","author":"Martinez","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111285_bb0085","article-title":"Ephenidine, diphenidine and methoxphenidine complications reported to the French Addictovigilance network: another brick in the wall!","volume":"32","author":"Megarbane","year":"2018","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0090","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.1620","article-title":"From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs","volume":"6","author":"Morris","year":"2014","journal-title":"Drug Test Anal."},{"issue":"4910","key":"10.1016\/j.pnpbp.2025.111285_bb0095","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.2660263","article-title":"Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs","volume":"244","author":"Olney","year":"1989","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111285_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000321803","article-title":"Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics","volume":"63","author":"P\u00e1len\u00ed\u010dek","year":"2011","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111285_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12906","article-title":"Naphyrone (naphthylpyrovalerone): pharmacokinetics, behavioural effects and thermoregulation in Wistar rats","volume":"26","author":"Pinterova-Leca","year":"2021","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0110","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2013"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111285_bib167","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1081\/CBI-120014572","article-title":"Treatment-time-dependent difference of ketamine pharmacological response and toxicity in rats","volume":"19","author":"Rebuelto","year":"2002","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113638","article-title":"New psychoactive substances (NPS) and serotonin syndrome onset: a systematic review","volume":"339","author":"Schifano","year":"2021","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111285_bb0120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbr.2009.02.007","article-title":"Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801","volume":"204","author":"Seillier","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111285_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/jpet.123.001942","article-title":"Phencyclidine-like abuse liability and psychosis-like neurocognitive effects of novel arylcyclohexylamine drugs of abuse in rodents","volume":"390","author":"Shaw","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111285_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13216","article-title":"Pharmacokinetics, systemic toxicity, thermoregulation and acute behavioural effects of 25CN-NBOMe","volume":"27","author":"\u0160\u00edchov\u00e1","year":"2022","journal-title":"Addict. Biol."},{"issue":"28","key":"10.1016\/j.pnpbp.2025.111285_bb0135","first-page":"17","article-title":"DescTools: tools for descriptive statistics","volume":"099","author":"Signorell","year":"2019","journal-title":"R Pack. Vers."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111285_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bph.15680","article-title":"Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats","volume":"179","author":"\u0160tefkov\u00e1-Mazochov\u00e1","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111285_bb0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/ilar.52.3.366","article-title":"The neurobehavioral pharmacology of ketamine: implications for drug abuse, addiction, and psychiatric disorders","volume":"52","author":"Trujillo","year":"2011","journal-title":"ILAR J."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111285_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/02791072.2014.974002","article-title":"\u201cWord of mouse\u201d: indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine","volume":"47","author":"Van Hout","year":"2015","journal-title":"J. Psychoactive Drugs"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111285_bb0155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","article-title":"A systems model of altered consciousness: integrating natural and drug-induced psychoses","volume":"56","author":"Vollenweider","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2025.111285_bb0160","series-title":"1, 2-Diarylethylamine-and Ketamine-Based New Psychoactive Substances. New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology","first-page":"305","author":"Wallach","year":"2018"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111285_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157021","article-title":"Pharmacological investigations of the dissociative \u2018Legal Highs\u2019 diphenidine, methoxphenidine and analogues","volume":"11","author":"Wallach","year":"2016","journal-title":"PLoS ONE"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:25:21Z","timestamp":1762284321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S0278584625000399"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111285","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The acute effects of methoxphenidine on behaviour and pharmacokinetics profile in animal model","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111285"}}